1. Zhu, Viola Weijia, Upadhyay, Daya, Schrock, Alexa B, Ali, Siraj M, Ou, Sai-Hong Ignatius. 2016. TPD52L1-ROS1, a new ROS1 fusion variant in lung adenosquamous cell carcinoma identified by comprehensive genomic profiling. In Lung cancer (Amsterdam, Netherlands), 97, 48-50. doi:10.1016/j.lungcan.2016.04.013. https://pubmed.ncbi.nlm.nih.gov/27237027/
2. Kamili, Alvin, Roslan, Nuruliza, Frost, Sarah, Chen, Yuyan, Byrne, Jennifer A. 2015. TPD52 expression increases neutral lipid storage within cultured cells. In Journal of cell science, 128, 3223-38. doi:10.1242/jcs.167692. https://pubmed.ncbi.nlm.nih.gov/26183179/
3. Roskoski, Robert. 2017. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers. In Pharmacological research, 121, 202-212. doi:10.1016/j.phrs.2017.04.022. https://pubmed.ncbi.nlm.nih.gov/28465216/
4. L'Espérance, Sylvain, Popa, Ion, Bachvarova, Magdalena, Têtu, Bernard, Bachvarov, Dimcho. . Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. In International journal of oncology, 29, 5-24. doi:. https://pubmed.ncbi.nlm.nih.gov/16773180/
5. Hong, Qin, Li, Bing, Cai, Xiumei, Zhong, Yunshi, Wen, Bo. 2021. Transcriptomic Analyses of the Adenoma-Carcinoma Sequence Identify Hallmarks Associated With the Onset of Colorectal Cancer. In Frontiers in oncology, 11, 704531. doi:10.3389/fonc.2021.704531. https://pubmed.ncbi.nlm.nih.gov/34458146/
智鼠故事 
